GUIDELINES FOR PREVENTION OF MATERNAL ANAEMIA

Similar documents
Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer )

BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY

Rh D Immunoglobulin (Anti-D)

Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject

cambodia Maternal, Newborn AND Child Health and Nutrition

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

Nutrition Promotion. Present Status, Activities and Interventions. 1. Control of Protein Energy Malnutrition (PEM)

Why your weight matters during pregnancy and after birth

117 4,904, making progress

Haemolytic disease of the newborn Burak Salgin

Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

150 7,114, making progress

68 3,676, making progress

NATIONAL DRUG POLICY ON MALARIA (2013)

Prenatal screening and diagnostic tests

PERINATAL NUTRITION. Nutrition during pregnancy and lactation. Nutrition during infancy.

Controlling Iron Deficiency Nutrition policy discussion paper No. 9

Why is prematurity a concern?

Laboratory confirmation requires isolation of Bordetella pertussis or detection of B. pertussis nucleic acid, preferably from a nasopharyngeal swab.

Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates

Which flu vaccine should you or your child

EFFECT OF DAILY VERSUS WEEKLY IRON FOLIC ACID SUPPLEMENTATION ON THE HAEMOGLOBIN LEVELS OF CHILDREN 6 TO 36 MONTHS OF URBAN SLUMS OF VADODARA

Preconception Clinical Care for Women Medical Conditions

Diabetes and pregnancy - Antenatal care

QUICK REFERENCE TO BLOOD BANK TESTING

What can happen if you have low iron levels?

Mother s blood test to check her unborn baby s blood group

OET: Listening Part A: Influenza

High quality follow up support and care

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

Guideline. Treatment of tuberculosis in pregnant women and newborn infants. Version 3.0

WHO Recommendations for the Prevention of Postpartum Haemorrhage Results from a WHO Technical Consultation October 18-20, 2006

PUBLIC HEALTH IMPROVEMENT PARTNERSHIP

Pregnancy and Tuberculosis. Information for clinicians

What women can do to optimise their health during pregnancy and that of their baby Claire Roberts

Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India

Women, Children and Sexual Health Division Maternity Services. Guideline: Anti D- Prophylaxis

ROYAL HOSPITAL FOR WOMEN

Nige g ri e an a N at a ional a Antimal a ari a a Tre re t a men e t g ide d l e ines

Exceptional People. Exceptional Care. Antenatal Appointment Schedule for Normal Healthy Women with Singleton Pregnancies

SiderAL is a Trademark owned by FOR THE TREATMENT OF ALL IRON DEFICIENCY RELATED ANEMIAS

National Outcome Measures and National Performance Measures Kansas Maternal and Child Health Services Block Grant 2016 Application/2014 Annual Report

Promoting Family Planning

Child and Maternal Nutrition in Bangladesh

POAC CLINICAL GUIDELINE

Obstetrics and Maternity

III CHAPTER 2. Antenatal Care. Ornella Lincetto, Seipati Mothebesoane-Anoh, Patricia Gomez, Stephen Munjanja

Appendix 4: Guidelines for Prescribing and Administering Drugs:

Neural Tube Defects - NTDs

Maternal and Neonatal Health in Bangladesh

2. What Should Advocates Know About Diabetes? O

NHS FORTH VALLEY B12 and Folate: A Practical Guide

Reduced Ovarian Reserve Is there any hope for a bad egg?

AUSTRALIA AND NEW ZEALAND FACTSHEET

MRP-No. DE/H/0279/001/P/002 Dr. Scheffler Vitamin C, 1000mg, effervescent tablets

How To Help Your Village Health And Nutrition Day

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Epidemiology 521. Epidemiology of Maternal and Child Health Problems. Winter / Spring, 2010

Ana M. Viamonte Ros, M.D., M.P.H. State Surgeon General

A Strategic Plan for Improving Preconception Health and Health Care: Recommendations from the CDC Select Panel on Preconception Care

ORGANIZATIONS. Organization Programmatic Areas of Focus Notes Interviewed? Yes. Averting Maternal Death and Disability (AMDD)

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo

Study on 2 Monthly Injectable Contraceptive Norethisterone Enanthate (200mg)

USPSTF Grade A B Recommendations

Nutrient Reference Values for Australia and New Zealand

Service Availability and Readiness Assessment (SARA)

MATERNAL AND CHILD HEALTH

Algorithm for Initiating Antidepressant Therapy in Depression

MATERNAL AND CHILD HEALTH 9

GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA

Choices about clamping your baby s umbilical cord: A decision aid for women having a vaginal birth

Birth defects. Report by the Secretariat

Methadone and Pregnancy

PREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION

Quality of Birth Certificate Data. Daniela Nitcheva, PhD Division of Biostatistics PHSIS

VITAMIN D PRODUCTS -WHAT AND WHEN TO PRESCRIBE. Claudette Allerdyce Principal Pharmacist Croydon CCG Pharmacy Team

GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR

All Wales Prescription Writing Standards

SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES

NUTRITIONAL REHABILITATION CENTRE

BUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE

Calcium Folinate Ebewe Data Sheet

High proportions of women in industrialized and


Major roles of neurocognitive developmental center are as follows:

NSW Pertussis Control Program 2015

Careers in Haematology

Global burden of Iron Deficiency Anaemia in the year 2000

Artificial insemination with donor sperm

MANAGEMENT OF INFANTS BORN TO HIV POSITIVE MOTHERS

Ministry of Health & Family Welfare. Operational Plan for Mother and Child Tracking System

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

Magee-Womens Hospital

VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS

IMAP Statement on Safe Abortion

SAMPLE. UK Obstetric Surveillance System. Management of Pregnancy following Laparoscopic Adjustable Gastric Band Surgery.

Guideline: Daily iron and folic acid supplementation in pregnant women

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

SUPPORTING WOMEN USING OPIATES IN PREGNANCY: A Guideline for Primary Care Providers May, 2011

FDA Update on the H1N1 Flu Vaccine and Antiviral Medications

Transcription:

1 Annexure-1 GUIDELINES FOR PREVENTION OF MATERNAL ANAEMIA As one of the important factors influencing maternal morbidity and mortality and also the health of the newborn, anaemia has defied over three decades of public health intervention and continues to affect a majority of pregnant women in the state. Anaemia in pregnancy is associated with high maternal morbidity and mortality. Maternal anaemia is associated with poor intra-uterine growth and conceiving of low-birth-weight babies. This in turn could result in higher perinatal morbidity, infant mortality, developmental delays, reduction of placental weight, volume and surface area. There is a striking difference in the mean birth weight of the infants born of anaemic and non-anaemic mothers. This has resulted in 12 to 28 percent of foetal loss, 30 percent of perinatal deaths and 7 to 10 percent of neonatal deaths. Anaemia during the second trimester is associated with preterm birth. Preterm delivery is increased fivefold for iron deficiency anaemia and doubled for other anaemia. Fifteen to twenty percent of maternal deaths are directly or indirectly due to anaemia and the mortality is higher if postpartum haemorrhage occurs in anaemic mothers. Causes for anaemia in women Low bio-availability of iron in food Inadequate intake of iron rich foods Excess consumption of coffee/tea Inadequate intake of folate. Inadequate intake of Vitamin B12. Worm infestation Menstrual loss of blood Chronic infections like malaria, TB

2 As the maternal anaemia is the serious concern for the state, for the prevention and control of anaemia and for provision of quality antenatal care, the expert committee/groups were formed in collaboration with State EmOC Nodal center and after various deliberations the expert committee has recommended suitable strategies with the following guidelines for the prevention and control of anaemia during pregnancy. Classification of Anaemia (ICMR-1989) Hb level <4g/dl Classification Very severe 4-6.9 g/dl Severe 7-9.9 g/dl Moderate 10-10.9 g/dl Mild a. Compulsory Haemoglobin estimation Compulsory Haemoglobin estimation by Cyanmeth-haemoglobin method by using Semi-autoanalyser or photo calorimeter at 14-16 weeks, 20-24 weeks, 26-30 weeks and 30-34 weeks of pregnancy for all pregnant mothers (minimum four Hb estimations). The interval between one haemoglobin estimation and another should have a minimum of four weeks. b. Deworming at 14-16 th week of gestation (Second Trimester) All pregnant women at 14-16 th week during the second trimester should be given one tablet of Albendazole 400mg single dose.

3 I. At 14-16 weeks First Hb estimation has to be done at 14-16 th week for all the antenatal mothers If the Hb is more than 11 gms, give prophylactic dose of IFA tablets. If the Hb is 7.1-10.9 gms%, give therapeutic dose of IFA tablets. If the Hb is less than 7 gms%, she has to be referred to CEmONC centres for Blood transfusion and further management. Iron in the form of Ferrous Sulphate is the best choice. Preventive/therapeutic form of oral iron therapy should be started after deworming. Prophylactic dose: Tab.IFA (100 mg. of iron with 0.5mg of folic acid) once daily for 100 days. Therapeutic dosage: Tab.IFA twice daily for 100 days II. At 20-24 weeks Second Haemoglobin estimation has to be done between 20 and 24 weeks of gestation for all AN mothers. If the Hb is more than 11 gms, give prophylactic dose of IFA tablets. If the Hb is 9-10.9 gms%, give therapeutic dose of IFA tablets. If haemoglobin level is between 7.1 to 8.9 gm/dl. IV Iron sucrose infusion has to be given.

4 Intra venous infusion of Iron sucrose 100 mg. in 100 ml of Normal saline infused over 20-30 minutes once a day x 4 days over a period of 2 weeks (with 2-4 days of interval between each infusion) Discontinue oral iron therapy while IV iron sucrose infusion till next Hb estimation and decision (after 4 weeks of Iron sucrose infusion).vitamin supplementation need not be withheld. If the Hb is less than 7 gms%, she has to be referred to CEmONC centres for Blood transfusion and further management. III. At 26-30 weeks Third Haemoglobin estimation has to be done between 26 and 30 weeks of gestation for all AN mothers. For Ante-natal mothers infused with iron sucrose infusion during 20-24 weeks, Haemoglobin estimation has to be done after one month. If the Hb is more than 11 gms, assure and counsel to continue with prophylactic dose of IFA tablets. If the Hb is 9-10.9 gms%, assure and counsel the mother for further improvement of Hb% and continue with therapeutic dose of IFA tablets. If the Hb is 7.1-8.9 gms% For mothers who received iron sucrose infusion, give two top up doses of 100 mgs of Iron sucrose infusion with 2-4 days interval between each infusion. For mothers who had not received Injection iron sucrose earlier during current pregnancy, give four

5 doses of iron sucrose injection (100 mg. in 100 ml of Normal saline infused over 20-30 minutes once a day x 4 days over a period of 2 weeks with 2-4 days of interval between each infusion) If the Hb is less than 7 gms%, she has to be referred to CEmONC centres for Blood transfusion and further management. IV. At 30-34 weeks All AN mothers have to be subjected to Hb estimation at 30-34 weeks irrespective of mode of management of anaemia previously. If the Hb is more than 11 gms, assure and counsel to continue with prophylactic dose of IFA tablets If the Hb is 9-10.9 gms%, assure and counsel the mother for further improvement of Hb% and continue with therapeutic dose of IFA tablets. If the Hb checked at 30-34 weeks does not improve (still less than 9 gms%), refer to higher institution for blood transfusion and further management. GENERAL GUIDELINES a) Trigger point for referral to higher institution a. Hb level of 7 gm% of haemoglobin at 14 weeks, 20-24 weeks, 26-30 weeks b. Hb level of 9 gms% at 30-34 weeks b) History a. History of repeated blood transfusions have to be asked for excluding haemoglobinopathies and bleeding diathesis. b. Previous history of any allergic reactions to any drug, bronchial asthma have to be asked.

6 Injection Iron Sucrose to be avoided in these women. c) Tests to be done a. Hb estimation by Cyanmeth-hemoglobin method using semiautoanalyser or photo calorimeter is mandatory in all institutions. b. Peripheral smear, MCV/RBC ratio, Serum iron binding capacity may be done in medical college, DHQ Hospitals and institutions with facilities for these tests. c. To rule out refractory anemia, urine should be checked for albumin, sugar and deposits. If deposits are more than 4-6 cells, then urine culture should be done. d) Safety aspects emphasised a. Infusion has to be completed within 30 minutes to avoid the release of free radicals. During the first 5 minutes give the infusion at the rate of 20-30 drops per minute. Then increase the rate of infusion to 80-90 drops per minute. b. Like any other drug, expiry date has to be confirmed before administration c. With respect to Normal Saline, the following points to be checked a. If any leakage is found, the bottle should be discarded b. Colour change, visible particles to be looked for. If any noticed such bottles to be discarded. c. While giving iron sucrose injection care should be taken not to allow extravasation of iron sucrose. To prevent this needle/venflon has to be secured (in position) correctly. d. Always look for the dosage content in the ampoules. If the ampoule contains 50 mg. of iron, 2 ampoules to be used. If the ampoule contains 100 mg of iron 1 ampoule to be used. Total dose should be 100 mg. of iron in 100 ml of normal saline for infusion at a time. d. Standard Emergency tray should be made available at the bedside for handling any reactions.

7 e. Pulse and BP to be recorded before, during and after the administration of Inj. Iron Sucrose infusion f. If any reaction is suspected, stop the infusion and treat for the reactions. List of items to be available is given in the annexure-3. e)diet counselling All the mothers should be encouraged to take iron rich foods and avoid coffee and tea. f)vitamin supplementation Water soluble vitamins like folic acid, B12 need not be withheld during iron sucrose infusion. g) Case sheets as in annexure-4 have to be maintained in every institution for proper follow-up care. h) Monthly stock and utilisation report should be sent in the format enclosed- annexure-5.

8 GUIDELINES FOR MANAGEMENT OF MATERNAL ANAEMIA FLOW CHART I. AT 14-16 WEEKS OF GESTATION:- Deworming with one 400 mg. of Tablet Albendozole after meals at 14-16 weeks First estimation of Blood Haemoglobin at 14-16 weeks of gestation by cyanmeth-haemoglobin method using semi- auto analyser or photocalorimeter level less than 7 gm./dl. level between 7.1-10.9gm/dl. level more than 11 gm/dl. Refer to Higher Institutions (CEmONC centres) for Blood transfusion and further management Theraputic dose of Tablet Ferrous sulphate 100 mg. of elemental iron 1 bd. with 0.5 mg. of folic acid 1 Tablet of Vitamin B12 15mcg. And Vitamin C 100 mg./od. to be supplemented. Preventive dose of Tablet Ferrous sulphate 100 mg. of elemental iron 1 od. 0.5mg of folic acid 1 Tablet of Vitamin B12 15mcg. And Vitamin C 100 mg./od. to be supplemented.

9 * If the AN registration done earlier than 14 weeks then oral iron to be started from 12 weeks onwards. II. AT 20-24 th WEEK OF GESTATION:- Second estimation of Blood at 20-24 weeks of gestation after the consumption of preventive/therapeutic dose of iron level less than 7 gm./dl. level between 7.1-8.9 gm./dl.** level is 9-11 gm/dl. level is more than 11 gm/dl. Refer to Higher Institutions (CEmONC centres) for Blood transfusion and further management 1 st dose 100 mg. of injection iron sucrose in 100 ml. of Normal saline infusion for 30 min. only. Injection iron sucrose infusion *** intra venous 4 doses of 100 mg. for 4 days over a period of 2 weeks with 2-4 days interval between each dose. 2 nd, 3 rd and 4 th dose (each 100 mg) over a period of 2 weeks, at 2-4 days interval- 100mg. of injection iron sucrose in 100 ml. of Normal saline infusion for 30 min. only Continue with therapeutic dose of Tablet Ferrous sulphate 100 mg. of elemental iron 1 bd. 1 Tablet of Vitamin B12 15mcg. And Vitamin C 100 mg./od. Continue with preventive dose of Tablet Ferrous sulphate 100 mg. of elemental iron 1 od. 1 Tablet of Vitamin B12 15mcg. And Vitamin C 100 mg./od.

10 ** Not to give oral iron while giving IV iron sucrose infusion. ie., oral iron to be with held till the 3 rd estimation of Haemoglobin results *** If there is any allergic reaction like urticaria which can be treated with 100 mg. hydrocortisone (1 ml. IV). While giving iron sucrose injection care should be taken not to allow extravasation of iron sucrose. To prevent this, venflon has to be secured (in position) correctly. Specification -If the ampoule contains 50 mg. of iron, 2 ampoules to be used. If the ampoule contains 100 mg of iron 1 ampoule to be used. Total dose should be 100 mg. of iron in 100 ml of normal saline for infusion at a time.

11 III. AT 26-30 WEEKS OF GESTATION:- Third estimation of Blood after 1 month of the above 4 doses (not later than 30 weeks ) level less than 7 gm./dl. level is 7.1-8.9 gm./dl. level is 9-11 gm./dl. level is more than 11 gm./dl Refer to Higher Institutions (CEmONC centres) for Blood transfusion and further management Not Received Inj. Iron sucrose earlier in the current pregnancy Injection iron sucrose infusion *** intra venous 4 doses of 100 mg. over a period of 2 weeks with 2-4 days interval. Received Inj. Iron sucrose earlier in the current pregnancy Assure and counsel the mother for the further improvement of Blood level and to continue ****oraliron supplementation till delivery Two top up doses of Injection iron sucrose infusion intra venous 100 mg(each) in 100 ml. of normal saline for 30 min. only (with 2-4 days interval between each dose) Continue with preventive dose of Tablet Ferrous sulphate 100 mg. of elemental iron 1 od. 1 Tablet of Vitamin B12 15mcg. And Vitamin C 100 mg./od.

12 IV. ****Continue preventive dose of iron (100 mg. of elemental iron) + 0.5 mg. of folic acid till delivery. AT 30-34 WEEKS OF GESTATIONS:- Estimation of Blood at 30-34 weeks of gestation level less than 7 gm/dl. level is 7.1-8.9 gm/dl level is 9-11 gm/dl. level is more than 11 gm/dl Refer to Higher Institutions (CEmONC Centres) for Blood transfusion and further management Refer to Higher Institutions (CEmONC Centres) for Blood transfusion And further management Assure and counsel the mother for the further improvement of Blood level and to continue ****oral iron supplementation till delivery Continue with preventive dose of Tablet Ferrous sulphate 100 mg. of elemental iron 1 od. 1 Tablet of Vitamin B12 15mcg. And Vitamin C 100 mg./od. ****Continue preventive dose of iron (100 mg. of elemental iron) + 0.5 mg. of folic acid till delivery.